Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity (Q37583668)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2015
edit
Language Label Description Also known as
English
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
scientific article published on May 2015

    Statements

    Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity (English)
    1 May 2015

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit